U.S. federal trademark · Serial No. 88916837 · Reg. No. 6521716
Scientific, medical and pharmaceutical research and development, namely, development of new pharmaceutical formulations, development of pharmaceutical formulations for efficient drug release, development of clinical uses and treatments for new chemical entities and known pharmaceutical compounds; research and development of new pharmaceutical formulations; research and development of pharmaceutical formulations for efficient drug release; research and development of pharmaceuticals, namely, pharmaceuticals for treating cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; research and development of new chemical entities and known pharmaceutical compounds; research and development of medicines, namely, for the treatment of cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; scientific investigations for medical purposes; research and development of medicines, namely, new chemical entities and known pharmaceutical compounds
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.